Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review

BACKGROUND: Iron supplementation and erythropoiesis-stimulating agent (ESA) administration represent the hallmark therapies in preoperative anemia treatment, as reflected in a set of evidence-based treatment recommendations made during the 2018 International Consensus Conference on Patient Blood Man...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Laermans, Jorien, Van Remoortel, Hans, Avau, Bert, Bekkering, Geertruida, Georgsen, Jørgen, Manzini, Paola Maria, Meybohm, Patrick, Ozier, Yves, De Buck, Emmy, Compernolle, Veerle, Vandekerckhove, Philippe
Formáid: Online Alt Téacs
Teanga:English
Foilsithe / Cruthaithe: BioMed Central 2022
Ábhair:
Research
Rochtain ar líne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578279/
https://www.ncbi.nlm.nih.gov/pubmed/36253838
http://dx.doi.org/10.1186/s13643-022-02081-5

Ar líne

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578279/
https://www.ncbi.nlm.nih.gov/pubmed/36253838
http://dx.doi.org/10.1186/s13643-022-02081-5

Míreanna comhchosúla